Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Louis Buscail, Barbara Bournet, Pierre Cordelier
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 3, pp. 153-168
Closed Access | Times Cited: 541

Showing 1-25 of 541 citing articles:

Pancreatic cancer: A review of epidemiology, trend, and risk factors
Jian-Xiong Hu, Chengfei Zhao, Chen WenBiao, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 27, pp. 4298-4321
Open Access | Times Cited: 378
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
Jie Cai, Hongda Chen, Ming Lu, et al.
Cancer Letters (2021) Vol. 520, pp. 1-11
Closed Access | Times Cited: 263
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen, Herbert J. Zeh, Rui Kang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 804-823
Closed Access | Times Cited: 238
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 231
KRAS mutation in pancreatic cancer
Ji Luo
Seminars in Oncology (2021) Vol. 48, Iss. 1, pp. 10-18
Open Access | Times Cited: 221
Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
Otília Menyhárt, Balázs Győrffy
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 949-960
Open Access | Times Cited: 218
The pancreatic cancer genome revisited
Akimasa Hayashi, Jungeui Hong, Christine A. Iacobuzio‐Donahue
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 7, pp. 469-481
Closed Access | Times Cited: 150
LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis
Hao Zhang, Changhao Zhu, Zhiwei He, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 141
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 134
DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism
Jing Du, Xu Wang, Yanchun Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 7
Open Access | Times Cited: 132
Current Advances in RNA Therapeutics for Human Diseases
Hannah Zogg, Rajan Singh, Seungil Ro
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2736-2736
Open Access | Times Cited: 124
Molecular Characterization ofKRASWild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A. Philip, Ibrahim Azar, Joanne Xiu, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 12, pp. 2704-2714
Open Access | Times Cited: 121
Lipidomic profiling of human serum enables detection of pancreatic cancer
Denise Wolrab, Robert Jirásko, Eva Cífková, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 119
Artificial Intelligence and Early Detection of Pancreatic Cancer
Barbara Kenner, Suresh T. Chari, David P. Kelsen, et al.
Pancreas (2021) Vol. 50, Iss. 3, pp. 251-279
Open Access | Times Cited: 115
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers
Hong‐Beom Park, Kwang‐Hyun Baek
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188736-188736
Closed Access | Times Cited: 98
Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling
Barath Udayasuryan, Raffae N. Ahmad, Tam T. D. Nguyen, et al.
Science Signaling (2022) Vol. 15, Iss. 756
Open Access | Times Cited: 72
Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154438-154438
Closed Access | Times Cited: 51
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
Xiangdong Lv, Xuan Lu, Jin Cao, et al.
Science (2023) Vol. 381, Iss. 6662
Open Access | Times Cited: 45
A sustainable approach to universal metabolic cancer diagnosis
Ruimin Wang, Shouzhi Yang, Mengfei Wang, et al.
Nature Sustainability (2024) Vol. 7, Iss. 5, pp. 602-615
Closed Access | Times Cited: 26
Targeting KRAS in pancreatic cancer
Sandra Stickler, Barbara H. Rath, Gerhard Hamilton
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 799-805
Open Access | Times Cited: 18
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D
Chuan Zhou, Zisheng Fan, Yuejiao Gu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1147-1167
Closed Access | Times Cited: 17
Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis
Seongryong Kim, Galam Leem, Junjeong Choi, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Advancements in clinical RNA therapeutics: Present developments and prospective outlooks
Phei Er Saw, Erwei Song
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101555-101555
Open Access | Times Cited: 16
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients
Di Jin, Najeeb Ullah Khan, Wei Gu, et al.
Neoplasia (2025) Vol. 60, pp. 101129-101129
Closed Access | Times Cited: 2
Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications
Haifeng Hu, Ye Zeng, Yi Qin, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 11, pp. 1725-1741
Open Access | Times Cited: 102
Page 1 - Next Page

Scroll to top